• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Prophase Labs Inc (NQ: PRPH )

    3.180 +0.080 (+2.58%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 30, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 21,598
    Open 3.180
    Bid (Size) 1.270 (2)
    Ask (Size) 3.290 (45)
    Prev. Close 3.100
    Today's Range 3.060 - 3.290
    52wk Range 3.010 - 7.550
    Shares Outstanding 18,045,209
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    PRPH Stock Earnings: ProPhase Labs Beats EPS, Misses Revenue for Q1 2024
    PRPH stock results show that ProPhase Labs beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
    Via InvestorPlace
    PRPH Stock Earnings: ProPhase Labs Misses EPS, Misses Revenue for Q4 2023
    PRPH stock results show that ProPhase Labs missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
    Via InvestorPlace

    Performance

    YTD
    -31.47%
    -31.47%
    1 Month
    -21.67%
    -21.67%
    3 Month
    -31.02%
    -31.02%
    6 Month
    -33.47%
    -33.47%
    1 Year
    -56.32%
    -56.32%

    More News

    Read More
    Earnings Scheduled For March 15, 2024
    Via Benzinga
    ProPhase Labs's Earnings: A Preview
    Via Benzinga
    ProPhase Labs Earnings Preview
    Via Benzinga
    Analyst Expectations for ProPhase Labs's Future
    Via Benzinga
    Recap: ProPhase Labs Q1 Earnings
    Via Benzinga
    Overview Of Value Stocks In The Healthcare Sector
    Via Benzinga
    ProPhase Labs Earnings Preview
    Via Benzinga
    Stocks That Hit 52-Week Lows On Tuesday
    Via Benzinga
    DSS, Inc.'s (NYSE American: DSS) Subsidiary Appoints New Chief Investment Officer To Aggressively Develop Mutual Fund Business For Eventual Spinoff
    Via Benzinga
    DSS Inc. Is Spinning Off Its Biotech Subsidiary After Signing A Major Licensing Agreement
    Via News Direct
    A Look Into Healthcare Sector Value Stocks
    Via Benzinga
    5 Value Stocks In The Healthcare Sector
    Via Benzinga
    ProPhase Labs's Return On Capital Employed Overview
    Via Benzinga
    5 Value Stocks In The Healthcare Sector
    Via Benzinga
    Stocks That Hit 52-Week Lows On Friday
    Via Benzinga
    DSS Inc. Is Spinning Off Its Biotech Subsidiary After Signing A Major Licensing Agreement
    Via TheNewswire.com
    DSS Inc. Is Spinning Off Its Biotech Subsidiary After Signing A Major Licensing Agreement
    Via Benzinga
    Earnings Scheduled For August 10, 2023
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    7 Small-Cap Biotech Stocks with Massive Potential
    Via InvestorPlace
    Impact Biomedical Preparing A Potential Spinoff — What Does This Mean For Investors Of Holding Company DSS, Inc (NYSE American: DSS)?
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    ProPhase Labs to Present at the Planet MicroCap Showcase: VIRTUAL 2022 on Wednesday, December 7, 2022
    From ProPhase Labs, Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.